The First Affiliated Hospital Of Xiamen University

This study looks at whether semaglutide, a common diabetes drug, affects bone density and fracture risk in people with type 2 diabetes. About 150 adults aged 50-75 will take either semaglutide plus metformin or metformin alone for 12 months. Researchers will measure bone density …

This early-stage study tests whether transplanting gut bacteria from young donors (fecal microbiota transplant) can make immunotherapy and chemotherapy work better for people with a hard-to-treat type of metastatic colorectal cancer (MSS mCRC). Ten patients aged 18-75 who have al…

This early-stage study tests a combination of two drugs—peginterferon alfa-2b and an anti-PD-1 antibody—in about 60 people with advanced or metastatic solid tumors that have stopped responding to standard treatments. The main goal is to find the safest dose and see if the combina…

This early-stage study tests whether adding two targeted drugs (pyrotinib and darcilib) to standard hormone therapy can shrink tumors before surgery in people with HR-positive, HER2-low breast cancer. The trial plans to enroll 33 patients with locally advanced disease. The main g…

This study will test whether two types of PET/CT scans can more accurately stage nasopharyngeal cancer and predict how well patients will respond to immunotherapy before treatment. Researchers will observe 732 adults with newly diagnosed cancer, measuring tumor activity on scans …